This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Griffiths, K. A. Articles by Celermajer, D. S. Search for Related Content PubMed PubMed Citation Articles by Griffiths, K. A. Articles by Celermajer, D. S.

Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease

Kaye A. Griffiths, DMU^*, Mark A. Sader, MBBS, FRACP, Michael R. Skilton, BSc^*, Jason A. Harmer, BSc^* and David S. Celermajer, MBBS, PhD, FRACP^*,*

^* Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia
Heart Research Institute, Sydney, Australia
Department of Medicine, University of Sydney, Sydney, Australia

View larger version (8K): [in a new window]   Figure 1 Study design: raloxifene and vascular reactivity.

View larger version (15K): [in a new window]   Figure 2 Effects of raloxifene and placebo on flow-mediated dilation (FMD) in postmenopausal women with coronary artery disease.